News Home

Should You Buy BIOLASE Inc (BIOL) Stock After it Has Risen 11.94% in a Week?

Tuesday, August 24, 2021 02:15 PM | InvestorsObserver Analysts
Should You Buy BIOLASE Inc (BIOL) Stock After it Has Risen 11.94% in a Week?

The market has been high on BIOLASE Inc (BIOL) stock recently. BIOL gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
BIOLASE Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on BIOL!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With BIOL Stock Today?

BIOLASE Inc (BIOL) stock is trading at $0.75 as of 2:14 PM on Tuesday, Aug 24, an increase of $0.03, or 4.78% from the previous closing price of $0.71. The stock has traded between $0.69 and $0.77 so far today. Volume today is below average. So far 3,594,336 shares have traded compared to average volume of 6,545,663 shares. To screen for more stocks like BIOLASE Inc click here.

More About BIOLASE Inc

Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States. Click Here to get the full Stock Report for BIOLASE Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App